Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02343172
Title Study of Safety and Efficacy of HDM201 in Combination With LEE011 in Patients With Liposarcoma
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications

liposarcoma

Therapies

Ribociclib + Siremadlin

Age Groups: adult
Covered Countries FRA | ESP | DEU | CAN

Additional content available in CKB BOOST